[1] JAESCHKE H.Acetaminophen:dose-dependent drug hepatotoxicity and acute liver failure in patients[J].Dig Dis, 2015, 33(4):464-471. [2] RAMACHANDRAN A, JAESCHKE H.Acetaminophen toxicity:novel insights into mechanisms and future perspectives[J].Gene Expr, 2018, 18(1):19-30. [3] 陈熠媛,陈硕崴,张谢,等.对乙酰氨基酚肝毒性研究进展[J].浙江医学, 2019:852-853, 858. [4] KHAN R, KOPPE S.Modern management of acute liver failure[J].Gastroenterol Clin North Am, 2018, 47(2):313-326. [5] WOOLBRIGHT B L, JAESCHKE H.Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure[J].J Hepatol, 2017, 66(4):836-848. [6] HENAO-MEJIA J, ELINAV E, JIN C C, et al.Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity[J].Nature, 2012, 482(7384):179-185. [7] 柯敏,李运璧.IRAK4在TLR介导的信号通路中的调节作用[J].实用医院临床杂志, 2016, 13(3):150-152. [8] MARINHO F V, FAHEL J S, SCANGA C A, et al.Lack of IL-1 receptor-associated kinase-4 leads to defective Th1 cell responses and renders mice susceptible to mycobacterial infection[J].J Immunol, 2016, 197(5):1852-1863. [9] KANG L L, ZHANG D M, MA C H, et al.Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation[J].Sci Rep, 2016, 6:27460. [10] WIESE M D, MANNING-BENNETT A T, ABUHELWA A Y.Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis[J].Expert Opin Investig Drugs, 2020, 29(5):475-482. [11] KHANFAR M A, ALQTAISHAT S.Discovery of potent IRAK-4 inhibitors as potential anti-inflammatory and anticancer agents using structure-based exploration of IRAK-4 pharmacophoric space coupled with QSAR analyses[J].Comput Biol Chem, 2019, 79:147-154. [12] ROELOFS B A, GE S X, STUDLACK P E, et al.Low micromolar concentrations of the superoxide probe MitoSOX uncouple neural mitochondria and inhibit complex IV[J].Free Radic Biol Med, 2015, 86:250-258. [13] PERELMAN A, WACHTEL C, COHEN M, et al.JC-1:alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry[J].Cell Death Dis, 2012, 3(11):e430. [14] LEE W M.Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away?[J].J Hepatol, 2017, 67(6):1324-1331. [15] YAN M Z, HUO Y Z, YIN S T, et al.Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions[J].Redox Biol, 2018, 17:274-283. [16] 李青霞,张玉彬.对乙酰氨基酚损伤肝线粒体造成肝衰竭的分子机制及应用[J].药学进展, 2019, 43(10):786-792. [17] LIANG Q N, SHENG Y C, JI L L, et al.Acetaminopheninduced cytotoxicity on human normal liver L-02 cells and the protection of antioxidants[J].Toxicol Mech Methods, 2010, 20(5):273-278. [18] SU L C, XU W D, HUANG A F.IRAK family in inflammatory autoimmune diseases[J].Autoimmun Rev, 2020, 19(3):102461. [19] WANG H, ZHOU H, ZHANG Q R, et al.Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice[J].J Hepatol, 2020, 73(6):1470-1481. |